Page last updated: 2024-10-22

amlodipine and Intertrochanteric Fractures

amlodipine has been researched along with Intertrochanteric Fractures in 1 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Puttnam, R1
Davis, BR1
Pressel, SL1
Whelton, PK1
Cushman, WC1
Louis, GT1
Margolis, KL1
Oparil, S1
Williamson, J1
Ghosh, A1
Einhorn, PT1
Barzilay, JI1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT00000542]Phase 30 participants Interventional1993-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for amlodipine and Intertrochanteric Fractures

ArticleYear
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.
    JAMA internal medicine, 2017, Jan-01, Volume: 177, Issue:1

    Topics: Aged; Amlodipine; Antihypertensive Agents; Chlorthalidone; Female; Follow-Up Studies; Hip Fractures;

2017